MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
30.94
-1.17 (-3.64%)
Dec 26, 2025, 10:32 AM EST - Market open
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.39 billion as of December 26, 2025. Its market cap has increased by 82.10% in one year.
Market Cap
1.39B
Enterprise Value
1.05B
1-Year Change
82.10%
Ranking
Category
Stock Price
$30.94
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.39B, an increase of 172.59%. That is a compound annual growth rate of 118.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 1.44B | 134.11% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |